QA/QC: challenges and pitfalls facing the microarray community and regulatory agencies
- 1 November 2004
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Molecular Diagnostics
- Vol. 4 (6) , 761-777
- https://doi.org/10.1586/14737159.4.6.761
Abstract
The scientific community has been enthusiastic about DNA microarray technology for pharmacogenomic and toxicogenomic studies in the hope of advancing personalized medicine and drug development. The...Keywords
This publication has 49 references indexed in Scilit:
- Toxicogenomics Data: The Road to AcceptanceEnvironmental Health Perspectives, 2004
- Microarrays demystified.Environmental Health Perspectives, 2004
- ArrayTrack--supporting toxicogenomic research at the U.S. Food and Drug Administration National Center for Toxicological Research.Environmental Health Perspectives, 2003
- Effects of Atmospheric Ozone on Microarray Data QualityAnalytical Chemistry, 2003
- Prostate cancer biomarkers: a current perspectiveExpert Review of Molecular Diagnostics, 2003
- Microarray data—the US FDA, industry and academiaNature Biotechnology, 2003
- Optimization of oligonucleotide-based DNA microarraysNucleic Acids Research, 2002
- An array of opportunitiesNature, 2002
- Expression profiling using microarrays fabricated by an ink-jet oligonucleotide synthesizerNature Biotechnology, 2001
- Genomics, gene expression and DNA arraysNature, 2000